TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sino Swed Biotech AB
Closing information (x1000 DKK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
1,059
|
995
|
1,212 |
| Financial expenses |
1
|
1
|
1 |
| Earnings before taxes |
307
|
233
|
416 |
| EBITDA |
307
|
234
|
416 |
| Total assets |
589
|
513
|
675 |
| Current assets |
589
|
513
|
675 |
| Current liabilities |
3
|
40
|
115 |
| Equity capital |
510
|
413
|
509 |
| - share capital |
63
|
66
|
72 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
86.6%
|
80.5%
|
75.4% |
| Turnover per employee |
530
|
498
|
606 |
| Profit as a percentage of turnover |
29.0%
|
23.4%
|
34.3% |
| Return on assets (ROA) |
52.3%
|
45.6%
|
61.8% |
| Current ratio |
19633.3%
|
1282.5%
|
587.0% |
| Return on equity (ROE) |
60.2%
|
56.4%
|
81.7% |
| Change turnover |
100
|
-111
|
-74 |
| Change turnover % |
10%
|
-10%
|
-6% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.